EPHB4-RASA1 regulation of lymphatic vessel valve development and function
EPHB4-RASA1 regulation of lymphatic vessel valve development and function
批准号:
10543485
负责人:
PHILIP D KING
金额:
$57.12万
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
未结题
起止时间:
2015-04-01 至 2025-01-31
关键词:
AdultApoptosisApoptoticBasement membraneBiologicalBloodBlood CirculationCardiovascular systemCell DeathCell membraneCellsCessation of lifeChylothoraxChylous AscitesCollagen Type IVDataDefectDepositionDevelopmentDiseaseEmbryoEndoplasmic ReticulumEph Family ReceptorsExtravasationFunctional disorderFundingGenesGoalsGrowth Factor ReceptorsGuanosine TriphosphateHealthHumanImmunityImpairmentInheritedIntercellular FluidInvestmentsKnowledgeLaboratoriesLifeLipidsLiquid substanceLymphLymphaticLymphatic CapillariesLymphatic DiseasesLymphatic Endothelial CellsLymphatic functionLymphedemaMaintenanceMedicalMethodologyMissionMolecularMusMuscle CellsMutationOutcomePathway interactionsPatientsPhysiologicalPlayPrevention therapyPublic HealthRas Signaling PathwayReceptor Protein-Tyrosine KinasesRegulationReportingRoleSignal TransductionSignal Transduction PathwaySystemTestingTissuesUnited States National Institutes of HealthVascular SystemVenousVertebratesadaptive immune responsebiological adaptation to stressblindbody cavityburden of illnesscell growthdisabilityexperimental studyinnovationlymph flowlymph nodeslymphatic developmentlymphatic valvelymphatic vesselmouse geneticsnovelnovel therapeuticsvascular factor
中文摘要
淋巴管系统在间质液体和脂质的运输中起着至关重要的作用,
以及在脊椎动物中诱导适应性免疫反应。淋巴管的正常功能
血管系统依赖于腔内淋巴瓣(LV),它促进血管的推进流动
收集淋巴管中的淋巴液体。左心室发育和功能缺陷导致心力衰竭。
淋巴充盈组织或体腔内的淋巴,导致淋巴水肿、乳糜胸和乳糜性腹水。
从医学角度,了解调节发育的分子机制
LV的功能是至关重要的,但我们对这些机制的了解仍然有限。我们已经重新-
先前移植了RASA1,它抑制了细胞内RAS信号转导的激活
途径,是左室发育和维持所必需的。此外,其他人也报告说
受体酪氨酸激酶EphB4是左心室发育所必需的。然而,精确的运动--
RASA1和EphB4调节LV的分子机制尚不清楚。中国的长期目标是
King实验室正在研究RAS信号通路在不同生理系统中的作用。
健康和疾病方面的主题。这个应用程序的总体目标与这一长期一致-
学期目标是了解RASA1如何调节左心室的发育和功能。我们的中央
假设RASA1通过与EphB4的物理相互作用促进胶原的输出
IV从LV形成(LVF)淋巴管内皮细胞(LEC)和成熟LEC中沉积。
分别为发育中和已建立的左心室叶的微细胞基质核心。这样做的理由是
研究表明,它们将揭示RASA1和EphB4调控的分子机制
LV的发展和功能。我们计划测试我们的中心假设,从而实现
通过追求以下两个具体目标来实现此应用程序的目标:在第一个目标中,我们将使用
不同的分子细胞生物学、小鼠遗传学和生理学方法来理解分子生物学和分子生物学。
RASA1缺失导致LV发育和维持失败的机制。在
第二个目标,我们将使用类似的方法来理解EphB4在
LV及其涉及的机制。拟议的研究具有创新性,因为方法新颖--
所采用的技术和概念,即EphB4-RASA1轴对于发育和
LV从LVF LEC和LV LEC输出IV型胶原的功能。这些研究具有重要意义,因为-
它们有可能导致预防和治疗左心室畸形的新疗法的原因
在RASA1和EphB4基因发生遗传突变的人类中。
英文摘要
The lymphatic vascular system plays an essential role in the transport of interstitial fluid and lipids,
and in the induction of adaptive immune responses in vertebrates. Normal functioning of the lymphatic
vascular system depends upon intraluminal lymphatic valves (LV) that facilitate propulsive flow of
lymph fluid in collecting lymphatic vessels. Defects in LV development and function results in accumu-
lation of lymph in tissues or body cavities resulting in lymphedema, chylothorax and chylous ascites.
From a medical perspective, understanding the molecular mechanisms that regulate the development
and function of LV is critical, yet our knowledge of these mechanisms remains limited. We have re-
ported previously that RASA1, which inhibits activation of the intracellular Ras signal transduction
pathway, is required for the development and maintenance of LV. In addition, others have reported
that the receptor tyrosine kinase, EPHB4, is required for LV development. However, the precise mo-
lecular mechanisms by which RASA1 and EPHB4 regulate LV are unknown. A long-term goal of the
King laboratory is to understand the role of the Ras signaling pathway in different physiological sys-
tems in health and disease. The overall objective of this application, which is consistent with this long-
term goal, is to understand how RASA1 regulates the development and function of LV. Our central
hypothesis is that RASA1, through physical interaction with EPHB4, promotes the export of collagen
IV from LV-forming (LVF) lymphatic endothelial cells (LEC) and mature LEC for deposition in the ex-
tracellular matrix core of developing and established LV leaflets respectively. The rationale for these
studies is that they will inform upon the molecular mechanisms by which RASA1 and EPHB4 regulate
the development and function of LV. We plan to test our central hypothesis and, thereby, attain the
objective of this application by pursuing the following two specific aims: In the first aim, we will use
different molecular cell biologic, mouse genetic, and physiological approaches to understand the mo-
lecular mechanism by which RASA1 loss results in failed development and maintenance of LV. In the
second aim, we will use similar approaches to understand the role of EPHB4 in the development of
LV and the mechanisms involved. The proposed studies are innovative because of the novel method-
ologies employed and the concept that an EPHB4-RASA1 axis is essential for the development and
function of LV acting to export collagen IV from LVF LEC and LV LEC. The studies are significant be-
cause of their potential to lead to new therapies for the prevention and treatment of LV abnormalities
in humans with inherited mutations in RASA1 and EPHB4 genes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Roles of Macropinocytosis in HIV-1 infection of CD4+ T Cells
-
批准号:10412160
-
项目类别:
-
资助金额:$65.25万
-
财政年份:2022
-
负责人:PHILIP D KING
-
依托单位:
Roles of Macropinocytosis in HIV-1 infection of CD4+ T Cells
-
批准号:10652492
-
项目类别:
-
资助金额:$64.25万
-
财政年份:2022
-
负责人:PHILIP D KING
-
依托单位:
The Structure and Function of Dental Lymphatics (R21)
-
批准号:10388309
-
项目类别:
-
资助金额:$23.4万
-
财政年份:2021
-
负责人:PHILIP D KING
-
依托单位:
Molecular pathogenetic mechanisms in CM-AVM
-
批准号:9883235
-
项目类别:
-
资助金额:$60.32万
-
财政年份:2020
-
负责人:PHILIP D KING
-
依托单位:
Molecular pathogenetic mechanisms in CM-AVM
-
批准号:10534770
-
项目类别:
-
资助金额:$51.88万
-
财政年份:2020
-
负责人:PHILIP D KING
-
依托单位:
Molecular pathogenetic mechanisms in CM-AVM
-
批准号:10319562
-
项目类别:
-
资助金额:$51.88万
-
财政年份:2020
-
负责人:PHILIP D KING
-
依托单位:
Lymphatic Vessel Abnormalities in CM-AVM
-
批准号:8884207
-
项目类别:
-
资助金额:$39.72万
-
财政年份:2015
-
负责人:PHILIP D KING
-
依托单位:
Lymphatic Vessel Abnormalities in CM-AVM
-
批准号:9034658
-
项目类别:
-
资助金额:$39.06万
-
财政年份:2015
-
负责人:PHILIP D KING
-
依托单位:
RASA1-mediated control of lymphatic vessel growth and function
-
批准号:8308412
-
项目类别:
-
资助金额:$35.33万
-
财政年份:2009
-
负责人:PHILIP D KING
-
依托单位:
RASA1-mediated control of lymphatic vessel growth and function
-
批准号:7688995
-
项目类别:
-
资助金额:$37.29万
-
财政年份:2009
-
负责人:PHILIP D KING
-
依托单位:
RASA1-mediated control of lymphatic vessel growth and function
-
批准号:8126210
-
项目类别:
-
资助金额:$35.77万
-
财政年份:2009
-
负责人:PHILIP D KING
-
依托单位:
RASA1-mediated control of lymphatic vessel growth and function
-
批准号:7903263
-
项目类别:
-
资助金额:$35.85万
-
财政年份:2009
-
负责人:PHILIP D KING
-
依托单位:
Control of T cell activation by the TSAd adapter protein
-
批准号:7083748
-
项目类别:
-
资助金额:$28.35万
-
财政年份:2002
-
负责人:PHILIP D KING
-
依托单位:
Control of T cell activation by the TSAd adapter protein
-
批准号:6751203
-
项目类别:
-
资助金额:$28.19万
-
财政年份:2002
-
负责人:PHILIP D KING
-
依托单位:
Control of T cell activation by the TSAd adapter protein
-
批准号:6544850
-
项目类别:
-
资助金额:$13.95万
-
财政年份:2002
-
负责人:PHILIP D KING
-
依托单位:
Control of T cell activation by the TSAd adapter protein
-
批准号:6908115
-
项目类别:
-
资助金额:$29.08万
-
财政年份:2002
-
负责人:PHILIP D KING
-
依托单位:
Control of T cell activation by the TSAd adapter protein
-
批准号:6697024
-
项目类别:
-
资助金额:$16.18万
-
财政年份:2002
-
负责人:PHILIP D KING
-
依托单位:
Control of T cell activation by the TSAd adapter protein
-
批准号:6640313
-
项目类别:
-
资助金额:$29.09万
-
财政年份:2002
-
负责人:PHILIP D KING
-
依托单位:
REGULATION OF CD28 SIGNAL TRNSDUCTION
-
批准号:6511069
-
项目类别:
-
资助金额:$17.85万
-
财政年份:1999
-
负责人:PHILIP D KING
-
依托单位:
REGULATION OF CD28 SIGNAL TRNSDUCTION
-
批准号:6362394
-
项目类别:
-
资助金额:$20.9万
-
财政年份:1999
-
负责人:PHILIP D KING
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: